Han Eui Seok, Choung Ho Kyung, Heo Jang Won, Kim Seong-Joon, Yu Young Suk
Department of Ophthalmology, Seoul National University College of Medicine, and Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Korea.
J AAPOS. 2006 Apr;10(2):155-8. doi: 10.1016/j.jaapos.2005.12.001.
We sought to investigate the effect of external subretinal fluid drainage (SRFD) on secondary or impending secondary glaucoma caused by bullous exudative retinal detachment for saving eyes with Coats' disease.
By retrospective chart review, we collected the treatment results of 56 patients younger than 15 years of age with Coats' disease. External SRFD was performed when exudative retinal detachment became bullous enough to cause anterior displacement of the lens-iris diaphragm or when secondary angle-closure glaucoma occurred. Treatment results were regarded as successful when secondary angle-closure glaucoma was prevented or responded to treatment.
The mean age of those who underwent external SRFD was 3.1+/-1.8 years. Exudative retinal detachment was found in 48 eyes (86%), and external SRFD was needed initially in 19 (28%). External SRFD initially was performed in 19 eyes (28%) and in 2 (3%) after initial cryotherapy. Of these 21 eyes, no definite neovascular glaucoma was detected, and it took on average 1.2 SRFDs to treat or prevent secondary angle-closure glaucoma. All treatments were successful, and no eye was enucleated.
External SRFD should be considered early as a treatment for secondary angle-closure glaucoma associated with bullous exudative retinal detachment in Coats' disease.
我们试图研究视网膜下液外引流(SRFD)对大泡性渗出性视网膜脱离所致继发性或即将发生的继发性青光眼的影响,以挽救患有科茨病的眼睛。
通过回顾性病历审查,我们收集了56例年龄小于15岁的科茨病患者的治疗结果。当渗出性视网膜脱离变得足够大泡以致引起晶状体-虹膜隔前移或发生继发性闭角型青光眼时,进行视网膜下液外引流。当继发性闭角型青光眼得到预防或对治疗有反应时,治疗结果被视为成功。
接受视网膜下液外引流的患者平均年龄为3.1±1.8岁。48只眼(86%)发现有渗出性视网膜脱离,19只眼(28%)最初需要进行视网膜下液外引流。19只眼(28%)最初进行了视网膜下液外引流,2只眼(3%)在初次冷冻治疗后进行了该操作。在这21只眼中,未检测到明确的新生血管性青光眼,治疗或预防继发性闭角型青光眼平均需要进行1.2次视网膜下液外引流。所有治疗均成功,无眼被摘除。
对于科茨病中与大泡性渗出性视网膜脱离相关的继发性闭角型青光眼,应尽早考虑视网膜下液外引流作为一种治疗方法。